emtricitabine has been researched along with tenofovir diphosphate in 23 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (4.35) | 29.6817 |
| 2010's | 11 (47.83) | 24.3611 |
| 2020's | 11 (47.83) | 2.80 |
| Authors | Studies |
|---|---|
| Amblard, F; Bassit, L; Bondada, L; Coats, SJ; Detorio, M; Grier, J; Hernandez-Santiago, BI; Koontz, D; Mellors, JW; Rapp, KL; Schinazi, RF; Sluis-Cremer, N | 1 |
| Amara, A; Back, D; Boffito, M; Dickinson, L; Else, L; Higgs, C; Jackson, A; Karolia, Z; Khoo, S; Moyle, G; Yapa, HM | 1 |
| Anderson, PL; Bushman, LR; Castillo-Mancilla, J; Guida, LA; Kiser, JJ; Klein, B; McAllister, K; Meditz, A; Rower, C; Zheng, JH | 1 |
| Callebaut, C; Cox, S; Das, M; Margot, N; McCallister, S; Miller, MD | 1 |
| Achterbergh, RCA; Anderson, PL; Cornelissen, M; de Bree, GJ; de Vries, HJC; Hoornenborg, E; Jurriaans, S; Kootstra, NA; Prins, JM; Prins, M; Reiss, P; Woittiez, LR | 1 |
| Anderson, PL; Buchbinder, S; Bushman, LR; Campbell, K; Castillo-Mancilla, JR; Gardner, EM; Ibrahim, M; Kiser, JJ; Liu, AY; MaWhinney, S; McHugh, C; Morrow, M; Seifert, SM; Wagner, T | 1 |
| Brewers, LM; Kashuba, ADM; Nicol, MR; Sykes, C | 1 |
| Anderson, PL; Arduino, RC; Ballerini, A; Bruno, G; Bushman, LR; Chua, CYX; Di Trani, N; Filgueira, CS; Folci, M; Gao, S; Grattoni, A; Gupte, M; Hood, RL; Hu, M; Jain, P; Marzinke, MA; Nehete, P; Sastry, JK; Shelton, K; Susnjar, A | 1 |
| Abrams, EJ; Brittain, K; Gomba, Y; Hu, NC; Maartens, G; Myer, L; Norman, J; Orrell, C; Phillips, TK; Sinxadi, P; Wiesner, L; Zerbe, A | 1 |
| Burack, JH; Erguera, X; Frazier, R; Grant, R; Horowitz, J; Kang Dufour, MS; Kennedy, K; Koester, KA; Myers, JJ; Packard, R; Udoh, I | 1 |
| Alexander, K; Anderson, PL; Brooks, KM; Bushman, LR; Castillo-Mancilla, JR; Ellison, L; Hosek, S; Huhn, GD; Ibrahim, ME; Kerr, BJ; Kiser, JJ; MaWhinney, S; McHugh, C; Tilden, S | 1 |
| Anderson, PL; Bacon, O; Buchbinder, SP; Cohen, S; Coleman, ME; Elion, R; Gandhi, M; Glidden, DV; Kolber, MA; Liu, AY; Scott, H; Spinelli, MA; Vittinghoff, E | 1 |
| Beksinska, M; Brown, TT; Eneh, P; Fowler, MG; Isingel, E; Kabwigu, S; Kaiser, T; Kiweewa Matovu, F; Nakalega, R; Nicol, MR; Staley, C; Sykes, C | 1 |
| Aizire, J; Brooks, KM; Butler, K; Cababasay, M; Fenton, T; Flynn, PM; Fowler, MG; Kiser, JJ; Mirochnick, M; Siberry, GK | 1 |
| Anderson, PL; Castillo-Mancilla, J; Chai, PR; Gandhi, M; Haberer, JE; Spinelli, MA | 1 |
| Anderson, PL; Brooks, KM; Bushman, LR; Castillo-Mancilla, J; Ibrahim, ME; Kiser, JJ; MaWhinney, S; McCallister, S; McHugh, C; Morrow, M; Yager, J | 1 |
| Anderson, PL; Bhasin, S; Defechereux, PA; Deutsch, MB; Glidden, DV; Grant, RM; O'Neal, J; Pellegrini, M; Sevelius, J; Yager, J; Yu, M | 1 |
| Anderson, PL; Bauer, R; Buschman, L; Charreau, I; Cotte, L; Cua, E; Delaugerre, C; Goldwirt, L; Laghzal, A; Liegeon, G; Meyer, L; Molina, JM; Mourah, S; Pialou, G | 1 |
| Dobard, C; García-Lerma, JG; Gary, J; Gatto, G; Heneine, W; Holder, A; Johnson, L; Khalil, G; Krovi, A; Li, L; Luecke, E; Massud, I; Mills, P; Mitchell, J; Nishiura, K; Pan, Y; Ruone, S; van der Straten, A | 1 |
| Anderson, PL; Blumenthal, J; Bolan, R; Burke, L; Chow, K; Corado, K; Dubé, MP; He, F; Henderson, P; Jain, S; Moore, DJ; Morris, SR; Sun, S | 1 |
| Brady, M; Chen, YQ; Cover, J; Cressey, TR; Drain, P; Duerr, A; Kariithi, E; Mori, K; Obanda, R; Obong'o, C; Okomo, G; Oluoch-Madiang, D; Tapsoba, JD | 1 |
| Anderson, PL; Brothers, J; Hosek, S; Huhn, G; Keckler, K; Liu, H; Xiong, D | 1 |
| Anderson, PL; Coyer, L; Davidovich, U; de Vries, HJ; Hoornenborg, E; Prins, M; Schim van der Loeff, MF; van den Elshout, MA | 1 |
1 review(s) available for emtricitabine and tenofovir diphosphate
| Article | Year |
|---|---|
Approaches to Objectively Measure Antiretroviral Medication Adherence and Drive Adherence Interventions.
Topics: Adenine; Adult; Anti-HIV Agents; Emtricitabine; Female; Hair; HIV Infections; Humans; Leukocytes, Mononuclear; Male; Medication Adherence; Monitoring, Ambulatory; Organophosphates; Pre-Exposure Prophylaxis; Tenofovir; Viral Load | 2020 |
9 trial(s) available for emtricitabine and tenofovir diphosphate
| Article | Year |
|---|---|
Plasma Tenofovir, Emtricitabine, and Rilpivirine and Intracellular Tenofovir Diphosphate and Emtricitabine Triphosphate Pharmacokinetics following Drug Intake Cessation.
Topics: Adenine; Adolescent; Adult; Aged; Anti-HIV Agents; Emtricitabine; Female; HIV Infections; Humans; Middle Aged; Organophosphates; Rilpivirine; Tenofovir; Young Adult | 2015 |
Intracellular Tenofovir-Diphosphate and Emtricitabine-Triphosphate in Dried Blood Spots following Directly Observed Therapy.
Topics: Adenine; Adult; Anti-HIV Agents; Cross-Over Studies; Directly Observed Therapy; Dried Blood Spot Testing; Emtricitabine; Female; HIV Infections; Humans; Male; Middle Aged; Organophosphates; Patient Compliance; Pre-Exposure Prophylaxis; Prospective Studies; Sexual and Gender Minorities; Young Adult | 2018 |
Pharmacokinetics of tenofovir monoester and association with intracellular tenofovir diphosphate following single-dose tenofovir disoproxil fumarate.
Topics: Adenine; Adult; Anti-HIV Agents; Blood Chemical Analysis; Cross-Over Studies; Emtricitabine; Female; HIV Infections; Humans; Male; Organophosphates; Phosphorous Acids | 2019 |
Antenatal Intracellular Concentrations of Tenofovir Diphosphate and Emtricitabine Triphosphate and Associations Between Tenofovir Diphosphate and Severe Adverse Pregnancy Outcomes: IMPAACT-PROMISE (1077BF) Trial.
Topics: Adenine; Anti-HIV Agents; Case-Control Studies; Chromatography, Liquid; Drug Combinations; Emtricitabine; Female; HIV Infections; Humans; Logistic Models; Lopinavir; Medication Adherence; Organophosphates; Polyphosphates; Pregnancy; Pregnancy Complications; Pregnancy Outcome; Retrospective Studies; Ritonavir; Tenofovir | 2020 |
Intracellular Tenofovir-Diphosphate and Emtricitabine-Triphosphate in Dried Blood Spots Following Tenofovir Alafenamide: The TAF-DBS Study.
Topics: Adenine; Adolescent; Adult; Alanine; Anti-HIV Agents; Cross-Over Studies; Drug Combinations; Emtricitabine; Female; HIV Infections; Humans; Male; Medication Adherence; Middle Aged; Organophosphates; Polyphosphates; Pre-Exposure Prophylaxis; Prospective Studies; Tenofovir; Young Adult | 2020 |
Sex Hormone Therapy and Tenofovir Diphosphate Concentration in Dried Blood Spots: Primary Results of the Interactions Between Antiretrovirals And Transgender Hormones Study.
Topics: Adenine; Anti-HIV Agents; Emtricitabine; Estradiol; Female; HIV Infections; Humans; Male; Organophosphates; Pre-Exposure Prophylaxis; Transgender Persons | 2021 |
Estimated pill intake with on-demand PrEP with oral TDF/FTC using TFV-DP concentration in dried blood spots in the ANRS IPERGAY trial.
Topics: Adenine; Adult; Anti-HIV Agents; Emtricitabine; Female; HIV Infections; Homosexuality, Male; Humans; Male; Medication Adherence; Organophosphates; Pre-Exposure Prophylaxis; Sexual and Gender Minorities; Tenofovir | 2021 |
Randomized Trial of Individualized Texting for Adherence Building (iTAB) Plus Motivational Interviewing for PrEP Adherence in Transgender Individuals: The iM-PrEPT Study.
Topics: Anti-HIV Agents; Emtricitabine; Female; HIV Infections; Humans; Male; Medication Adherence; Motivational Interviewing; Pre-Exposure Prophylaxis; Text Messaging; Transgender Persons | 2022 |
The ATEAM study: Advances in technology to enhance PrEP adherence monitoring (ATEAM) among young men who have sex with men.
Topics: Adolescent; Adult; Anti-HIV Agents; Cross-Over Studies; Emtricitabine; Female; HIV Infections; Homosexuality, Male; Humans; Male; Medication Adherence; Sexual and Gender Minorities; Technology; Tenofovir; Young Adult | 2022 |
13 other study(ies) available for emtricitabine and tenofovir diphosphate
| Article | Year |
|---|---|
Anti-human immunodeficiency virus activity, cross-resistance, cytotoxicity, and intracellular pharmacology of the 3'-azido-2',3'-dideoxypurine nucleosides.
Topics: Anti-HIV Agents; Cell Line, Tumor; Cell Survival; Cells, Cultured; Dideoxynucleosides; HIV Infections; HIV-1; Humans; Molecular Structure; Reverse Transcriptase Inhibitors | 2009 |
Application of an intracellular assay for determination of tenofovir-diphosphate and emtricitabine-triphosphate from erythrocytes using dried blood spots.
Topics: Adenine; Biological Assay; Dried Blood Spot Testing; Emtricitabine; Erythrocytes; Hematocrit; HIV Infections; Humans; Medication Adherence; Methanol; Organophosphates; Polyphosphates; Reproducibility of Results; Solutions; Temperature; Water | 2016 |
Infrequent development of drug resistance in HIV-1-infected treatment-naive subjects after 96 weeks of treatment with elvitegravir/cobicistat/emtricitabine/tenofovir alafenamide or elvitegravir/cobicistat/emtricitabine/tenofovir disoproxil fumarate.
Topics: Adenine; Amino Acid Substitution; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Cobicistat; Drug Resistance, Viral; Emtricitabine; Genotype; HIV Infections; HIV-1; Humans; Microbial Sensitivity Tests; Mutation; Organophosphates; Phenotype; Tenofovir | 2017 |
Acquisition of wild-type HIV-1 infection in a patient on pre-exposure prophylaxis with high intracellular concentrations of tenofovir diphosphate: a case report.
Topics: Adenine; Anti-HIV Agents; Emtricitabine; HIV Infections; HIV Seropositivity; HIV-1; Homosexuality, Male; Humans; Lymphogranuloma Venereum; Male; Medication Adherence; Middle Aged; Organophosphates; Pre-Exposure Prophylaxis; RNA, Viral; Tenofovir; Transgender Persons; Urinary Tract Infections | 2017 |
The role of menopause in tenofovir diphosphate and emtricitabine triphosphate concentrations in cervical tissue.
Topics: Adenine; Adult; Aged; Anti-HIV Agents; Cervix Uteri; Chromatography, Liquid; Emtricitabine; Female; Humans; Menopause; Middle Aged; Organophosphates; Tandem Mass Spectrometry; Young Adult | 2018 |
Transcutaneously refillable nanofluidic implant achieves sustained level of tenofovir diphosphate for HIV pre-exposure prophylaxis.
Topics: Adenine; Administration, Cutaneous; Animals; Antiviral Agents; Drug Delivery Systems; Emtricitabine; Equipment Design; HIV Infections; Humans; Infusion Pumps, Implantable; Lab-On-A-Chip Devices; Macaca mulatta; Organophosphates; Pre-Exposure Prophylaxis | 2018 |
A Comparison of Plasma Efavirenz and Tenofovir, Dried Blood Spot Tenofovir-Diphosphate, and Self-Reported Adherence to Predict Virologic Suppression Among South African Women.
Topics: Adenine; Adult; Alkynes; Anti-HIV Agents; Anti-Retroviral Agents; Benzoxazines; Cross-Sectional Studies; Cyclopropanes; Emtricitabine; Female; HIV Infections; Humans; Logistic Models; Organophosphates; Plasma; Self Report; South Africa; Tenofovir | 2019 |
Adherence to PrEP Among Young Men Who Have Sex With Men Participating in a Sexual Health Services Demonstration Project in Alameda County, California.
Topics: Adenine; Adolescent; Adult; Black or African American; California; Emtricitabine; HIV Infections; Homosexuality, Male; Humans; Male; Medication Adherence; Organophosphates; Pre-Exposure Prophylaxis; Sexual Behavior; Sexual Health; Young Adult | 2019 |
Brief Report: Short-Term Adherence Marker to PrEP Predicts Future Nonretention in a Large PrEP Demo Project: Implications for Point-of-Care Adherence Testing.
Topics: Adenine; Adult; Anti-HIV Agents; Dried Blood Spot Testing; Emtricitabine; Female; HIV Infections; Homosexuality, Male; Humans; Male; Medication Adherence; Organophosphates; Point-of-Care Testing; Pre-Exposure Prophylaxis; Proportional Hazards Models; Prospective Studies; Tenofovir | 2019 |
Depot Medroxyprogesterone Acetate and the Vaginal Microbiome as Modifiers of Tenofovir Diphosphate and Lamivudine Triphosphate Concentrations in the Female Genital Tract of Ugandan Women: Implications for Tenofovir Disoproxil Fumarate/Lamivudine in Preexp
Topics: Adenine; Anti-HIV Agents; Cytidine Triphosphate; Dideoxynucleotides; Emtricitabine; Female; HIV Infections; Humans; Lamivudine; Medroxyprogesterone Acetate; Microbiota; Organophosphates; Pre-Exposure Prophylaxis; Tenofovir; Uganda | 2020 |
Safety and efficacy of a biodegradable implant releasing tenofovir alafenamide for vaginal protection in a macaque model.
Topics: Absorbable Implants; Alanine; Animals; Anti-HIV Agents; Emtricitabine; Female; HIV; HIV Infections; Macaca; Necrosis; Simian Immunodeficiency Virus; Tenofovir | 2022 |
Continued attendance in a PrEP program despite low adherence and non-protective drug levels among adolescent girls and young women in Kenya: Results from a prospective cohort study.
Topics: Adenine; Adolescent; Adult; Anti-HIV Agents; Child; Contraceptive Agents; Diphosphates; Emtricitabine; Female; HIV Infections; Humans; Infant; Kenya; Male; Medication Adherence; Organophosphates; Pre-Exposure Prophylaxis; Prospective Studies; Tenofovir; Young Adult | 2022 |
Determinants of adherence to daily PrEP measured as intracellular tenofovir diphosphate concentrations over 24 months of follow-up among men who have sex with men.
Topics: Anti-HIV Agents; Emtricitabine; Follow-Up Studies; HIV Infections; Homosexuality, Male; Humans; Male; Medication Adherence; Pre-Exposure Prophylaxis; Sexual and Gender Minorities; Sexual Behavior | 2023 |